Portfolio News
- May 09, 2013
Trevena Inc. and Forest Laboratories Announce Development Collaboration For TRV027 - May 08, 2013
Portola Announces Its Factor Xa Inhibitor Antidote PRT4445 Produces Rapid, Sustained and Dose-Related Reversal of the Anticoagulant Activity of Eliquis® in Phase II Study - May 07, 2013
Ablynx Starts Pre-Clinical Development of ALX-0962, an Anti-IgE Nanobody, to Treat Severe Allergic Asthma - May 02, 2013
AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting - May 02, 2013
Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral Therapy ETC-1002 Lowered LDL-C By Up to 43 - May 02, 2013
Insulet to Develop New Version of the OmniPod Insulin Pump for Use With Humulin R U-500 Concentrated Insulin for People With Type 2 Diabetes
